Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3829_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
14 Мб
Скачать
☆
been disappointing, and published long-term results are
https://t.me/med1917
absent. Comparisons between liquid and foam sclerother­apy have been done, and the results strongly favor foam.
20,21
Ultrasound-guided sclerotherapy (USGS) with foam must be considered as a completely new treatment of varicose veins. Although it needs proper training and some skill, it is simple, a ordable, and extremely e cient.
Sclerosing agents produce a lesion of the venous wall, predominantly of the endothelium and, to a minor extent, of the media.  e reaction that follows depends on the con­centration of the agent and on the duration of the contact. If the venous diameter is greater than 3mm, injections of liq­uid do not achieve this aim and dilution with blood quickly decreases their e cacy at short distances from the point of injection. Injections of foam have the advantage of a total  lling of the vein, at least under 12mm diameter. Afurther reduction in venous diameter can be obtained by leg eleva­tion, compression with the hand, duplex probe or bandage, and venous spasm. In very large veins, foam will  oat over blood and induce a lesion of the upper venous wall despite apparent correct  lling of the vein observed on duplex, thus the importance of massaging and compression.
Making the foam is easy and quick. Based on the tech­nique initially described by Tessari, it can be prepared with
20
two 5-cc syringes and a three-way stopcock.
Only deter­gent sclerosing agents can be used: Sotradecol and poli­docanol at any desired concentration from 0.25% to 3%. Microbubbles of foam sclerosing agents are hyperechogenic and represent an excellent contrast medium for ultrasound techniques.  ey appear as a shadow within the lumen early, and like a hyperechogenic mass later with an acoustic shadow. Massaging the sclerosing agent to the desired part of the varicose network with the duplex probe or the hand is also very easily carried out. Progression from the varicose clusters to the GSV and then to the SFJ is always visible, provided a su cient volume has been injected. Venous spasm usually is observed within minutes.  e importance of the initial spasm has been emphasized in several studies
22,23
and protocols.
Postsclerotherapy compression is mandatory: on the varicose clusters for 48 hours, and then whole limb com­pression with 20- to 30-mm Hg thigh-high medical elastic
24
stockings.
 ey must be worn during the daytime for at least 15days. Patients must be examined both clinically and with duplex at 7 to 15days.
 e absolute risk of deep venous thrombosis is not con­ rmed. Afew cases have been reported:most of them are gastrocnemius vein thrombosis, typically a er telangiec­tasia and reticular vein sclerotherapy. Most frequent com­plications are visual disorders.  ese adverse reactions have been observed also with liquid sclerosing agents, but their incidence is much higher with foam; they can be estimated
25
 ey are observed more frequently in patients su ering from migraine with visual aura.  ey usually reproduce this aura. Researchers have
questioned the pathophysiology of this phenomenon but have received no answer so far.  e existence of a patent foramen ovale is the most likely explanation, as has been the liberation of toxic component associated with endothelial cell destruction (endothelin).
All published results demonstrate an immediate e cacy better than 80% in terms of immediate/primary venous occlusion. Repetition of injections in case of initial failure allows closure to approach 95% of e cacy with two to three sessions. Early and midterm results demonstrate a recur­rence rate of about 20%.  e redo injections remain as sim­ple as primary injections and at least as e cient.
R E F E R E N C E S
1. Takase S , Pascarella L , Bergan J , Schmid-Schönbein , GW .
Hypertension-induced venous valve remodeling, J Vasc Surg . 2004 . 39 : 1329–1334 .
2. Takase S , Pascarella L , Lerond L , Bergan JJ , Schmid-Schönbein GW .
Venous hypertension, in ammation, and valve remodeling , Eur J Vasc Endovasc Surg . 2004 . 28 : 484–493 .
3. Pascarella L , Schmid-Schönbein GW , Bergan JJ . An animal model
of venous hypertension: e role of in ammation in venous valve failure , J Vasc Surg . 2005 . 41 : 303–311 .
4. Pascarella L , Schmid-Schönbein GW , Bergan JJ . Microcirculation
and venous ulcers, Ann Vasc Surg . 2005 . 19 ( 6 ): 921–927 .
5. Mashiah A , Ross SS , Hod I .  e scanning electron microscope in the
pathology of varicose veins, Isr J Med Sci . 1991 . 27 : 202–206 .
6. Travers JP , Brookes CE , Evans J, etal. Assessment of wall structure and
composition of varicose veins with reference to collagen, elastin, and smooth muscle content , Eur J Vasc Endovasc Surg . 1996 . 11 : 230–237 .
7. Gradman WS , Segalowitz J , Grundfest W . Venoscopy in varicose
vein surgery:Initial experience , Phlebology . 1993 . 8 : 145–150 .
8. Van Cleef IF , Desvaux P , Hugentobler JP, etal. Endoscopie veineuse ,
J Mal Vasc . 1991 . 16 : 184–187 .
9. Van Cleef JF , Desvaux P , Hugentobler JP, etal. Etude endoscopique
des re ux valvulaires sapheniens, J Mal Vasc . 1992 . 17 : 113–116 .
10. Ono T , Bergan JJ , Schmid-Schönbein GW , Takase S . Monocyte
in ltration into venous valves , J Vasc Surg . 1998 . 27 : 158–166 .
11. Satokawa H , Hoshino S , Igari T . Angioscopic external valvu-
loplasty in the treatment of varicose veins , Phlebology . 1997 . 12 : 136–141 .
12. Wilkinson LS , Bunker C , Edwards JC , Scurr JH , Coleridge Smith
PD . Leukocytes: eir role in the etiopathogenesis of skin damage in venous disease , J Vasc Surg . 1993 . 17 : 669–675 .
13. Sarin S , Scurr JH , Coleridge Smith PD . Stripping of the long saphe-
nous vein in the treatment of primary varicose veins, Br J Surg . 1994 . 81 : 1455–1458 .
14. Dwerryhouse S, Davies B , Harradine K , etal. Stripping of the long
saphenous vein reduces the rate of reoperation for recurrent vari­cose veins:Five year results of a randomized trial , J Vasc Surg . 1999 . 29 : 589–592 .
15. Jones L , Braithwaite BD , Selwyn D , etal. Neovascularisation is the
principal cause of varicose vein recurrence:Results of a randomised trial of stripping the long saphenous vein , Eur J Vasc Endovasc Surg 1996 . 12 : 442–445 .
16. Woodyer AB , Dormandy JA . Is it necessary to strip the long saphe-
nous vein?, Phlebology . 1986 . 221–224 .
17. Min RJ , Zimmet SE , Isaacs MN , Forrestal MD . Endovenous laser
treatment of the incompetent greater saphenous vein , JVIR . 2001 . 12 : 1167–1171 .
18. Lurie F , Creton D , Eklof B , etal. Prospective randomized study of
endovenous radiofrequency obliteration (Closure Procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study) , J Vasc Surg . 2003 . 38 : 207–214 .
.
138 • PRIMARY SUPERFICIAL VENOUS INSUFFICIENCY
19. Morrison NM . Saphenous ablation:What are the choices, laser, or
https://t.me/med1917
RF energy?, Semin Vasc Surg . 2005 . 18 ( 1 ): 15–18 .
20. Tessari L , Cavezzi A , Frullini A . Preliminary experience with a new sclerosing foam in the treatment of varicose veins , Dermatol Surg . 2001 . 27 : 58–60 .
20. Yamaki T , Nozaki M , Iwasaka S . Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of super cial venous insu ciency, Dermatol Surg . 2004 . 30 ( 5 ): 718–722 ; discussion722.
21. Hamel-Desnos C , Desnos P , Wollmann JC , Ouvry P , Mako S , Allaert FA . Evaluation of the e cacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein:Initial results, Dermatol Surg . 2003 . 29 ( 12 ): 1170– 1175 ; discussion1175.
22. Frullini A , Cavezzi A . Sclerosing foam in the treatment of varicose veins and telangiectases:History and analysis of safety and compli­cations , Dermatol Surg. 2002 . 28 ( 1 ): 11–15 .
23. Barrett JM , Allen B , Ockelford A , Goldman MP . Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs, Dermatol Surg . 2004 . 30 ( 1 ): 6–12 .
24. Barrett JM , Allen B , Ockelford A , Goldman MP . Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a sub­group with diameters at the junction of 10mm or greater compared with a subgroup of less than 10mm, Dermatol Surg . 2004 . 30 ( 11 ): 1386–1390 .
25. Guex JJ , Allaert FA , Gillet JL , Chleir F . Immediate and midterm complications of sclerotherapy:Report of a prospective multicenter registry of 12,173 sclerotherapy sessions , Dermatol Surg . 2005 . 31 ( 2 ): 123–128 ; discussion 128.
OVERVIEW:TREATMENT OF VENOUS INSUFFICIENCY • 139
17.
https://t.me/med1917
ULTRASOUND EXAMINATION OF THE PATIENT
WITH PRIMARY VENOUS INSUFFICIENCY
Nicole Loerzel , Virginia Ratcli , Nisha Bunke-Paquette , and John J.  Bergan
INTRODUCTION
Chronic venous insu ciency (CVI) is a common disor­der whose manifestations include varicose veins and skin changes such as venous dermatitis, hyperpigmentation, lipodermatosclerosis, and chronic leg ulcers.  e signs and symptoms identifying CVI have been clearly demon­strated to be related to venous hypertension. tors, such as age, gender, hormones, body posture, genetic inheritance, and employment in standing occupations are associated with the development of venous hypertension.  is, in turn, has been found to trigger vascular remodeling, through a reorganization of extracellular matrix within the venous parenchyma.  is leads to the failure of vein valves.
Primary valve incompetence is the most important cause of venous hypertension (70–80% of cases). Valve incompe­tence may be secondary to deep venous thrombosis (DVT) or trauma in 18–25% and due to a congenital anomaly in
7
1–3% of cases.
 e advent of duplex ultrasonography has provided the physician with practical information to assess varicose veins, deep veins, thrombotic states, postthrombotic obstruction, and incompetent perforating veins.
8
examination is an essential diagnostic tool in the evaluation and treatment of venous disorders. Precision anatomical vein mapping and identi cation of patterns of venous re ux are essential to determine therapeutic options.
E Q U I P M E N T
 e duplex ultrasound system should be able to detect
9
blood  ow rates as low as 6 cm/s.
 is can be done by dedicated high resolution vascular scanners with Color/ Power-Doppler functions and pulsed-wave Doppler. Linear transducers in the range of 4–7 MHz are used. rior vena cava (IVC), pelvic veins, and deep veins in obese patients may be imaged with 3-MHz transducers.
1,2
Several fac-
3,4
5,6
Duplex ultrasound
7
 e infe-
With advances in technology, duplex systems have become smaller, more transportable, and more operator friendly. Miniaturized devices feature transducers designed with advanced architecture that allow a single probe to image across a greater range of depths within an application and across applications.  e transducer for peripheral vascu­lar examinations operates from 5–10 MHz and provides res­olution from skin surface to 7cm in depth.  e technology incorporates power Doppler sonography, tissue harmonic imaging, and direct connectivity to a personal computer.
Additional materials needed for a complete examina­tion include a warm room, acoustic gel, towels, handled step stools, and a comprehension worksheet.
CLINICAL EXAMINATION
 e clinical examination and complete medical history, will help determine the need for venous duplex ultrasound evaluation. Data concerning family and personal venous history, symptoms, clinical  ndings, and previous venous treatments should be elicited.
Limbs should be classi ed into one of seven CEA P classes of increasing severity designated C
to C 6 (see Table17.1)
0
and identi ed as symptomatic (S)or asymptomatic (A). Common symptoms associated with CVI are leg idling, heaviness, and sensation of itching and swelling; important signs to consider are skin hyperpigmentation, varicose veins, corona phlebectatica, venous dermatitis, lipodermatoclero­sis, active ulcers, and/or scars from previous ulceration.  e term “chronic venous disease” (CVD) is used for the full spectrum of signs and symptoms associated with classes C
, and the term “CVI” is used for classes C 4 toC 6 . 11
to C
6
A history of previous DVT or pulmonary embolism provides information regarding etiology.  e method of diagnosing DVT always should be recorded.  e anatomic distribution and the pathophysiology within the CEAP sys­tem are revealed by the ultrasound examination.
10
0.s
140
Table17.1 CEAP CLASSIFICATION OF CVD ANDCVI 17
https://t.me/med1917
CLASS SIGNS OF VENOUS DISEASE
Class 0
Class 1 (A,S) Class 2 (A,S) Class 3 (A,S) Class 4 (A,S)
Class 5 (A,S) Class 6 (A,S)
No visible or palpable signs of venous disease (only
symptoms) Telangiectasias or Reticular Veins Varicose Veins Edema Skin changes ascribed to venous disease (e.g.,
pigmenta tion, venous eczema, lipodermatosclerosis) Skin changes as de ned above with healed ulceration Skin changes as de ned above with active ulceration
INDICATIONS FOR DUPLEX
EVALUATION
Its generally accepted that all patients presenting with vari­cose veins, skin changes associated with chronic venous insu ciency, edema, leg ulceration (CEAP clinical stages 2–6) should undergo duplex ultrasound evaluation. Duplex scanning is also indicated to further evaluate patients with venous symptoms (CEAP clinical stage 0), venous malforma-
12
tions and for post-treatment surveillance.
It is the authors opinion that select patients with telangiectactic or reticular veins (CEAP clinical stage 1) should also be scanned for underlying venous insu ciency. Patients who have exten­sive reticular veins and/or telangiectasias, especially located in the inner thighs, medial or lateral malleolus or associated with corona phlebectasia are more likely to have underlying venous insu ciency than patients with minimal or isolated spider veins.  e Edinborough Vein Study showed there was a signi cant trend between grade of telangiectasias and re ux in the GSV (upper and lower segments) in the
13,14
limbs of 1092 subjects.
Engelhorn demonstrated either
greater or small saphenous vein re ux in 46% of patients
15
with CEAP 1 telangiectasias.
Other clinical signs such as corona phlebectasia, as de ned as fan-shaped intradermal telangiectases in the medial and sometimes lateral portions of the ankle and foot has been associated with an increased
16
prevalence of GSV re ux.
Additionally, risk of underlying incompetence in the calf perforators by duplex ultrasound is 4.4 times greater in patients with corona phlebectasia.
16
Patients who have failed spider vein treatment should also be evaluated for an underlying source of venous re ux.
ULTRASOUND EXAMINATION
Table17.2 SUMMARY OF IMPORTANT CHANGES IN
NOMENCLATURE OF LOWER EXTREMITY VEINS
OLD TERMINOLOGY NEW TERMINOLOGY
Femoral Vein Super cial Femoral Vein Deep Vein of the thigh Greater/Long Saphenous
Vein
Smaller/Short Saphenous
Vein Sural Veins Dodd’s Perforator Boyd’s Perforator Sherman’s Perforator
(24cm) Cockett’s Perforators
when the patient is supine.
Common Femoral Vein Femoral Vein Profunda Femoris Vein Great Saphenous Vein Small Saphenous Vein Solcal Veins Gastrocnemius Veins Medial Gastrocnemius Vein Lateral Gastrocnemius Vein Intergemellar Vein Perforator of the Femoral Canal Paratibial Perforator (upper third
of the leg)
Paratibial Perforator (middle third of
the leg)
Posterotibial Perforators
8,18,19
It is further recommended that the patient stand for several minutes prior to a duplex exami­nation, allowing for equilibration of the venous system.  e standing examination of the lower extremity venous system has become the standard of care and the supine examination should be considered inadequate. If the patient is physically unable to stand or if the history reveals a tendency to fainting because of vasovagal response, the examination may need to be modi ed with the patient in the semi-upright position.
VEIN MAPPING.
Transverse rather than longitudinal scans, and continuous scanning are performed in order to provide a clear mapping of the venous system.  is can be recorded on a premade data sheet simultaneously with the venous re ux examination (see Figure 17.1). Patency usually is assessed by compression of the vein, and re ux is detected on release.  e augmen­tation of  ow, distal compression, and release of thigh and
7
should be done sharply and quickly. Automated rapid
calf in ation/de ation cu s are cumbersome but may be used for this purpose, and o er the advantage of a standardized
8,20
stimulus.
 e Valsalva maneuver is a reverse  ow aug­mentation stimulus and is best used for the saphenofemoral junction (SFJ) because a competent valve at that level will render the test useless on more distal segments.
19,25
In 2002, an international interdisciplinary consensus com­mittee on venous anatomical terminology proposed a revi­sion and extension of the Terminologia Anatomica of the lower extremity venous system (see Table17.2).
 e ultrasound examination is carried out with the patient standing in an upright position. challenging venous valves and maximally dilates the leg veins. Sensitivity and speci city in detecting re ux are increased in examinations performed with the patient standing rather than
ULTRASOUND EXAMINATION OF THE PATIENT WITH PRIMARY VENOUS INSUFFICIENCY • 141
17
18
 is position elicits re ux by
R E F L U X
 e presence of vein re ux through incompetent vein valves is the most important pathologic  nding in CVI. Re ux is measured during the release phase of the  ow augmentation maneuver and during the closed epiglottis apneic phase of the Valsalva maneuver (see Figure17.2). It should be noted
Right
https://t.me/med1917
Left
Femoral Vein
SFJ
1.08 cm
GSV
58 cm;
48 cm;
0.36 cm
Figure17.1  is data entry form outlines the saphenous veins and the relevant deep veins. Re uxing veins are added in heavy black lines and selected vein diameters are recorded. Location of PVs and aneurysms can be added and distance from the  oor indicated.
0.41 cm
34 cm;
0.22 cm
Vein of Giacomini
22 cm; 0.76 cm
AP 2.2 × LL 1.9 cm
that retrograde back ow is present in normal vein valves immediately before their closure, but a cuto value of 500 ms de nes pathologic re ux in the saphenous veins.  e value of 350 ms is used in perforator veins (PVs) and 1,000ms for
18,21
femoropopliteal veins.
Time of day is a relative consen-
sus regarding the position for re ux determination.
SFJ 1.19 cm
Posterior Accessory
Venous
Aneurysm
16 cm; 0.6 cm 10 cm; 0.8 cm
Anterior Accessory
Anterior Arch
36 cm; 0.65 cm
19 cm; 0.46 cm “Reentry” PV
SPJ
0.80 cm
SSV
and deep femoral veins are identi ed (see Figure 17.3).  e SFJ also known as the con uence of super cial ingui­nal veins, is complex and highly variable. It includes the great saphenous vein (GSV), pudendal veins, and super­ cial epigastric and super cial circum ex iliac veins (see
17,22
Figure 17.4A).
Imaging of the pudendal veins is par­ticularly important in cases of pelvic congestive syndrome, in which vulvar varicosities and pudendal re ux can be
THE SAPHENOFEMORAL JUNCTION
With the patient standing and the transducer gently applied in the groin, the SFJ, common femoral vein, femoral vein,
observed. important cause of this syndrome.
the femoral vein is recorded.  e SFJ is usually the location
23
Incompetence of the ovarian veins is the most
24
 e diameter of the SFJ at the con uence of the GSV and
AB
Figure17.2 Flow augmentation maneuvers elicit re ux in incompetent veins. Re ux is de ned as retrograde out ow measured during the release phase of the augmentation maneuver and the Valsava maneuver’s closed epiglottis apneic phase for the SFJ only. Figure17.2 (A)demonstrates examination of a normal GSV. In contrast, Figure17.3 (B)demonstrates an incompetent GSV with re ux duration greater than 3 seconds.
142 • PRIMARY SUPERFICIAL VENOUS INSUFFICIENCY
https://t.me/med1917
Figure17.3 A transverse scan of the SFJ is displayed. Major anatomic land­marks to be noted are femoral vein, femoral artery, SFJ diameter, GSVs.
25
of the terminal valve. as subterminal, is also identi able (see Figure17.4B).
More distally another valve, known
25
 e Valsalva and thigh/calf compression-release maneu­vers de ne the presence of re ux at the saphenofemoral junction as well as in the femoralvein.
T H E  G S V
 e GSV is scanned from the groin in proximal-to-distal direction.
In the thigh, the GSV lies within the saphenous compart-
17
ment (see Figure17.5).
 e super cial fascia and the muscular fascia de ne the saphenous compartment and provide the typ­ical ultrasound image of an Egyptian eye (see Figure17.5C).
25
Anterior and posterior accessory veins are o en identi ed in the thigh (see Figure17.6).  ese veins are o en incompetent and receive re ux from the saphenous
17
vein.
Varying patterns of re ux through the di erent compo­nents of the SFJ and GSV system have been documented. Classi cation of abnormal, re uxing venous patterns has been a di cult task because of the anatomic variabil­ity of the vascular structures involved. In 2005 a panel of experts proposed a new classi cation of GSV re ux describing the di erent types and extent of GSV insu -
26,27
ciency (Figure17.7).
Furthermore, using this classi ca­tion system, Chastanet and Pittaluga have demonstrated that the more extensive the GSV re ux, the more it was positively correlated with increasing age and advanced
28
clinical stage.
Younger patients were more likely to have non-saphenous varicose veins with less advanced clinical signs. Older patients were more likely to have incompe­tence at the saphenofemoral junction and GSV re ux to theankle.
Diameters of the GSV, should be measured with B-mode ultrasound in transverse section at several lev­els.  ese measurements should be recorded at proximal, middle, and distal regions and especially at diameter varia­tion locations.  e term “super cial venous aneurysms” has been proposed for segmental dilations of the GSV and
29
small saphenous vein (SSV).
 e term “varicosities” refers to more elongated and dilated super cial veins.  e level, distance from the heel pad or  oor, and anteroposterior and laterolateral diameters of venous aneurysms should be
29
recorded.
Intersaphenous veins are o en present as communica-
tions between the GSV andSSV.
Figure17.4 ( A)  e SFJ includes the GSV, the super cial iliac circum ex, the super cial epigastric, and the pudendal veins. (B)Illustration of the SFJ with its valves. Modi ed from the De Venarum Ostiolis of Jeronimus Fabricius ab Aquapendente, Venice, 1603. TV, Terminal valve; PTV, preterminal valve; SSV, suprasaphenic valve; ISV, infrasaphenic valve. (Adapted from Reference25.)
ULTRASOUND EXAMINATION OF THE PATIENT WITH PRIMARY VENOUS INSUFFICIENCY • 143
A
Supercial
Circumex
Iliac Vein
Anterior
Accessory
Vein
Supercial
Epigastric
Junction
GSV
B
Vein
SSV
TV
ISV
Pudendal
Vein
PTV
Posterior
Accessory
Vein
A
https://t.me/med1917
SAPHENOUS CONPARTMENT
C
SUPERFICIAL
COMPARTMENT
DEEP
COMPARTMENT
B
SN
MUSCLE
DERMIS
ASV
GSV
FV
FA
ASV
(ASV = ACCESSORY SAPHENOUS VEINS)
SL
*
SAPHENOUS
FASCIA
SAPHENOUS
COPARTMENT
MUSCULAR FASCIA
MF
Figure17.5 ( A)  e saphenous compartment (SaphC) is bound super cially by the saphenous fascia (SF) and deeply by the muscular fascia (MF). It contains the saphenous veins (SV) and the saphenous nerve (SN).  e accessory saphenous veins (ASV) lie external to this compartment, close to the dermis (D). SC, Super cial compartment; DC, deep compartment. (Adapted from Reference 17.) (B)Axial section from a cadaveric limb.  e GSV enclosed in the saphenous compartment is clearly visualized. MF, Muscular fascia; SL saphenous ligament. (Adapted from Reference 25.) (C)Sonography of the GSV at mid thigh.  e hyperechoic saphenous fascia (SF) and muscular fascia (MF) de ne the saphenous compartment in which the GSV courses.
T H E  S S V
 e SSV is an important and o en overlooked cause of
super cial venous insu ciency.  e SSV usually empties in
 e posterior leg should be carefully interrogated prior to venous treatment, due to the variability in its anatomy and proximity to nerves and arteries.  e patient should stand and facing opposite the examiner.  e knee should be slightly bent, heel on the ground and weight bearing on the opposite limb.  e study of the SSV starts at the popli­teal fossa by identi cation of the saphenopopliteal junction (SPJ). Compression-release of the calf provides information concerning junctional re ux. If re ux is present in the SSV, the diameter of the small saphenous vein should be mea-
12
sured 3cm distal to the SPJ and at mid-calf.
to the popliteal vein directly or via the gastrocnemius vein, but there are many anatomic variations in its points of con­nection to the poplitealvein.
A thigh extension (TE), also known as the cranial exten-
30
sion of the SSV, is present in the majority of limbs.
It can
be identi ed between the biceps femoris and semimembra-
17
nous muscles.
 e TE of the SSV may give rise to vein of
Giacomini, that connects with the GSV in the posteriome-
17
dial aspect of the thigh.
In the calf, the SSV courses within
a duplication of the super cial fascia similar to the GSV in
19
the saphenous compartment.
AB
Figure17.6 (A) SFJ in the longitudinal view. (B)  e SFJ in transverse view will demonstrate the presence of accessory saphenous veins.
144 • PRIMARY SUPERFICIAL VENOUS INSUFFICIENCY
Mapping
https://t.me/med1917
igh or calf
tributary
Type 1 Type 2a
Isolated Suprafascial
reux
Incompetent
tributary or
perforator
+/–
reentry
perforator
Incompetent
tributary or
perforator
Reentry
perforator
reentry
perforator
Incompetent
tributary or
perforator
+/–
Incompetent
tributary or
perforator
Reentry
perforator
Type 2b Type 2c Type 2d
Isolated Suprafascial reux
Incompetent
tributary
Reentry
perforator
Type 3a Type 3b Type 4a Type 4b Type 5
Mixed reux with junctional
competence
Mixed reux with junctional
incompetence
SAV reux with junctional
incompetence
Figure17.7 In 2005, a panel of experts proposed a new classi cation to he used in a prospective multicenter study testing the A.S.V.A.L. (selective ablation of varicose veins in local anesthesia) method.  e classi cation reports  ve major types of saphenofemoral re ux.
 roughout the entire examination, compression-release
maneuvers ser ve to elicit re ux in the various venous segments
should be recorded. Many authors have observed a corre­lation between an enlarged perforating vein diameter and incompetence. One study reported that perforating diame­ters of 3.5mm or larger in the calf and thigh were associated
PERFORATINGVEINS
with re ux in more than 90% of cases.
31
Re ux is assessed by manual compression and release PVs penetrate anatomic layers (see Figure 17.8). Comm­unicating veins, such as intersaphenous veins, connect veins
17
within the same anatomic layer.
One of the innovations of the new Terminologia Anatomica of the venous system of lower limbs is the com­plete elimination of eponyms such as the Boyd, Sherman, and Cockett perforators. Descriptive terms designating
17
location have been adopted.
A classi cation of them is
shown in Table17.3. No doubt, all the eponyms will persist.
During the examination, the location of each perforator is recorded by measuring its distance (in centimeters) from the  oor.  e diameter (in centimeters) of each perforator
maneuvers. Blood  ow direction and duration following the compression must benoted.
It has been suggested that an outward (toward the super ­cial veins) blood  ow of duration greater than 350ms, follow­ing manual distal compression, de nes a PV as incompetent.
Perforators can be distinguished as exit and reentry veins. Exit veins are re uxing perforators usually associ­ated with clusters of varicose veins and/or important skin
7
changes, such as hyperpigmentation.
Reentry perforators usually are found distal to major varicose veins and clusters.  eir blood  ow direction is inward (toward the deep veins) and they are not pathologic
7
ULTRASOUND EXAMINATION OF THE PATIENT WITH PRIMARY VENOUS INSUFFICIENCY • 145
Table17.3 PERFORATING VEINS 19
https://t.me/med1917
MAIN GROUPS SUBGROUPS
Foot perforators Medial foot PV
Ankle Perforators Anterior Ankle PV
Leg Perforators Medial Leg PV
A
Knee Perforators Medial Knee PV
 igh Perforators Medial  igh PV
B
Plantar foot PV Dorsal foot PVs or intercapillary veins Plantar PV
Medial Ankle PV Lateral Ankle PV
Paratibial PV Posterior Tibial PV Anterior Leg Lateral Leg Posterior Leg Medial Gastrocnemius Lateral Gastrocnemius Intergemellar PV Para-achillean PV
Suprapatellar PV Lateral P.V Infrapatellar PV Popliteal Fossa
PV of the femoral canal Inguinal PV Anterior thigh PV Lateral thigh PV Posterior  igh PVs Pudendal PV
C
Figure17.8 PVs penetrate anatomic layers (A). Distal limb compression rather than proximal (B and C) elicits re ux. Re ux is measured on the release phase of the augmentation maneuver and is detected as outward  ow (B)whose duration is greater than in incompetent exit perforators. Reentry perforators show little or no outward  ow following distal compressions(C).
but merely competent. 7 Skin changes are not seen adjacent to reentry perforatingveins.
Incompetent perforators usually are observed at the
medial thigh, middle and distal third of the leg, and middle
7,9
third of the calf.
Scanning of the lateral aspect of the lower limb also is recommended.  e lateral venous system that is seen on the lateral aspect of the thigh and the leg can show varicosities and important exit and reentry perforators.  ese are not as well characterized as the medial perforatingveins.
ULTRASOUND MAPPING OF
VENOUSULCER S
Venous ulcers usually are associated with varicose veins and re uxing perforators located in the immediate vicinity of the ulcerated area. Asuper cial network of enlarged and dilated veins o en can be observed underneath the ulcer
32
(see Figure 17.9).
 e description and the documenta-
tion of re ux in these veins can help to indicate a particular
32–34
therapeutic approach.
D E E P  V E I N S
 e ultrasound examination also must include the deep veins. Femoral and popliteal veins usually are studied with
35
the patient in supine position.
Patency is assessed by distal compression. Irregularities of the vascular wall may appear as hyperechoic areas and always should be noted in patients with super cial re ux and a clinical history suggestive of previous DVT or pulmonary embolism. Sural, anterior tibial, posterior tibial, and peroneal veins are imaged while the patient is in the sitting position, usually starting from
35
the ankle and proceeding toward the knee.
Compression
and  ow augmentation maneuvers assess their patency
146 • PRIMARY SUPERFICIAL VENOUS INSUFFICIENCY
Proximal
v
https://t.me/med1917
ein
Distal vein
Subcutaneous layer
Subfascial layer
Perforating
Figure17.9 A network of varicose veins and incompetent perforators is o en identi ed in the vicinity of venous ulcers usually beneath theulcer.
and presence of re ux. Deep vein abnormalities must be recorded.
DISCUSSION
Duplex ultrasound sonography represents the best choice
7–9
in evaluation of venous re ux in lower limbs.
 is test is noninvasive, generally acceptable to the patient, and inex­pensive. It provides direct imaging, localization, and extent of venous re ux with a surprisingly high sensitivity (95%)
36
and speci city (100%).
Duplex ultrasound  ndings correlate with the angio-
scopic observation of incompetent vein valves in advanced
37
chronic venous insu ciency.
As demonstrated by Yamaki etal., high peak re ux velocities (>30cm/s), re ux duration greater than 3 s, and an enlarged valve annulus measured
vein
Table17.4 MAJOR INTERROGATION POINTS FOR VENOUS REFLUX EXAMINATION
INTERROGATION POINTS
Femoral vein
Saphenofemoral junction
Great saphenous vein
Accessory veins (anterior and posterior)
Popliteal vein-gastrocnemius Veins
Small saphenous vein
 igh Extension
Vein of Giacomini
Intersaphenous veins
Medial thigh PVs
Leg PVs
Ankle PVs
Perforating vein
by duplex ultrasonography at the SFJ are closely related to angioscopically deformed and incompetent terminal valves
37
(Type III and Type IV valves).
In contrast, duplex ultrasound PV identi cation and
characterization have shown to be more di cult and less
36
accurate.
Lower sensitivity rates (51%) have been reported
indicated in Table 17.4.  ese serve as basic guidelines because the interested vascular ultrasonographer must trace out duplicated veins and note re ux in major tributaries, such as the accessoryveins.
when the number of perforators identi ed by ultrasound, ascending phlebography (AP), and subfascial endoscopic
36
perforator surgery (SEPS) were compared.
C O N C L U S I O N
Duplex ultrasound sonography is the optimal diagnostic modality for assessment of lower extremity re ux. Insights into pathology, proper technique, and uniform testing
9
are essential.
A clear graphic notation of signi cant vein diameters, anomalous anatomy, super cial venous aneu­rysms, PVs, and presence and extent of re ux should always be recorded during the examination.  e most important interrogation points for the venous re ux examination are
1. Takase S , Bergan J . Molecular mechanisms in chronic venous insuf­ ciency . Ann Vasc Surg . 2007 . 21 ( 3 ): 260–266 . Review.
2. Bergan JJ , Pascarella L , Schmid-Schenbein GW . Pathogenesis of pri­mary chronic venous disease:Insights from animal models of venous hypertension . J Vasc Surg . 2008 . 47 ( 1 ): 183–92 . Review.
3. Criqui MH , Denenberg JO , Bergan J , Langer RD , Fronek A . Risk factors for chronic venous disease:the San Diego Population Study . J Vasc Surg . 2007 . 46 ( 2 ): 331–337 .
4. Evans CJ , Fowkes FG , Ruckley CV , Lee AJ . Prevalence of varicose veins and chronic venous insu ciency in men and women in the general population:Edinburgh Vein Study , J Epidemiol Community Health . 1999 . 53 ( 3 ): 149–153 .
5. Takase S , Pascarella L , Bergan JJ , Schmid-Schonbein GW . Hypertension induced venous valve remodeling, J Vasc Surg . 2004 . 39 ( 6 ): 1329–1334 .
R E F E R E N C E S
ULTRASOUND EXAMINATION OF THE PATIENT WITH PRIMARY VENOUS INSUFFICIENCY • 147